Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandria Phan

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2008
Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumorsCamilo Jimenez, Maria E Cabanillas, Libero Santarpia, et al.
Annals of Surgery|April 26, 2005
Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT)Stephen G Swisher, Wayne Hofstetter, Tsung T Wu, et al.
Cancers|January 28, 2026
Impact of Neoadjuvant Induction Chemotherapy Prior to Chemoradiation on Survival and Surgical Outcomes in Real-World Esophageal Adenocarcinoma CohortThomas M Matoska, Abdullah A Memon, Lou-Anne Acevedo Moreno, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 10, 2006
Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinomaS Chris Malaisrie, Wayne L Hofstetter, Arlene M Correa, et al.
The Annals of Thoracic Surgery|July 24, 2007
Proposed modification of nodal status in AJCC esophageal cancer staging systemWayne Hofstetter, Arlene M Correa, Neby Bekele, et al.
Cancer Research|October 24, 2025
Mutant and Wild-type RAS Crosstalk and Stoichiometric Deficiencies are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal AdenocarcinomaMandana Kamgar, G Aaron Hobbs, Raven Davidson, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2008
Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumorsCamilo Jimenez, Maria E Cabanillas, Libero Santarpia, et al.
Annals of Surgery|April 26, 2005
Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT)Stephen G Swisher, Wayne Hofstetter, Tsung T Wu, et al.
Cancers|January 28, 2026
Impact of Neoadjuvant Induction Chemotherapy Prior to Chemoradiation on Survival and Surgical Outcomes in Real-World Esophageal Adenocarcinoma CohortThomas M Matoska, Abdullah A Memon, Lou-Anne Acevedo Moreno, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 10, 2006
Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinomaS Chris Malaisrie, Wayne L Hofstetter, Arlene M Correa, et al.
The Annals of Thoracic Surgery|July 24, 2007
Proposed modification of nodal status in AJCC esophageal cancer staging systemWayne Hofstetter, Arlene M Correa, Neby Bekele, et al.
Cancer Research|October 24, 2025
Mutant and Wild-type RAS Crosstalk and Stoichiometric Deficiencies are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal AdenocarcinomaMandana Kamgar, G Aaron Hobbs, Raven Davidson, et al.
Pageof 4